Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 9.77
NAS:EDAP's Cash to Debt is ranked higher than
74% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. NAS:EDAP: 9.77 )
Ranked among companies with meaningful Cash to Debt only.
NAS:EDAP' s Cash to Debt Range Over the Past 10 Years
Min: 0.37  Med: N/A Max: No Debt
Current: 9.77
Equity to Asset 0.52
NAS:EDAP's Equity to Asset is ranked lower than
99.99% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. NAS:EDAP: 0.52 )
Ranked among companies with meaningful Equity to Asset only.
NAS:EDAP' s Equity to Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.4 Max: 1
Current: 0.52
0.25
1
Interest Coverage 0.34
NAS:EDAP's Interest Coverage is ranked lower than
100% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: 69.16 vs. NAS:EDAP: 0.34 )
Ranked among companies with meaningful Interest Coverage only.
NAS:EDAP' s Interest Coverage Range Over the Past 10 Years
Min: 7.63  Med: 7.63 Max: 7.63
Current: 0.34
F-Score: 5
Z-Score: 2.55
WACC vs ROIC
5.43%
24.38%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 1/10

vs
industry
vs
history
Operating margin (%) 4.79
NAS:EDAP's Operating margin (%) is ranked higher than
55% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 2.72 vs. NAS:EDAP: 4.79 )
Ranked among companies with meaningful Operating margin (%) only.
NAS:EDAP' s Operating margin (%) Range Over the Past 10 Years
Min: -18.31  Med: -12.16 Max: 1.51
Current: 4.79
-18.31
1.51
Net-margin (%) 11.48
NAS:EDAP's Net-margin (%) is ranked higher than
80% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 1.24 vs. NAS:EDAP: 11.48 )
Ranked among companies with meaningful Net-margin (%) only.
NAS:EDAP' s Net-margin (%) Range Over the Past 10 Years
Min: -53.64  Med: -18.89 Max: 6.93
Current: 11.48
-53.64
6.93
ROE (%) 29.51
NAS:EDAP's ROE (%) is ranked higher than
94% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. NAS:EDAP: 29.51 )
Ranked among companies with meaningful ROE (%) only.
NAS:EDAP' s ROE (%) Range Over the Past 10 Years
Min: -111.74  Med: -26.8 Max: 9.74
Current: 29.51
-111.74
9.74
ROA (%) 16.88
NAS:EDAP's ROA (%) is ranked higher than
98% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: 0.05 vs. NAS:EDAP: 16.88 )
Ranked among companies with meaningful ROA (%) only.
NAS:EDAP' s ROA (%) Range Over the Past 10 Years
Min: -31.62  Med: -13.18 Max: 3.46
Current: 16.88
-31.62
3.46
ROC (Joel Greenblatt) (%) 49.03
NAS:EDAP's ROC (Joel Greenblatt) (%) is ranked lower than
51% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 4.17 vs. NAS:EDAP: 49.03 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:EDAP' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -65.88  Med: -36.08 Max: 23.45
Current: 49.03
-65.88
23.45
Revenue Growth (3Y)(%) -10.30
NAS:EDAP's Revenue Growth (3Y)(%) is ranked lower than
77% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. NAS:EDAP: -10.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NAS:EDAP' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -17.3  Med: -2.35 Max: 10.9
Current: -10.3
-17.3
10.9
EPS Growth (3Y)(%) -48.70
NAS:EDAP's EPS Growth (3Y)(%) is ranked lower than
94% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. NAS:EDAP: -48.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NAS:EDAP' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -48.7  Med: -19.4 Max: 253.6
Current: -48.7
-48.7
253.6
» NAS:EDAP's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-11-19)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

EDAP Guru Trades in Q3 2015

Robert Bruce 1,345,494 sh (-14.05%)
» More
Q4 2015

EDAP Guru Trades in Q4 2015

Robert Bruce 1,045,494 sh (-22.30%)
» More
Q1 2016

EDAP Guru Trades in Q1 2016

Robert Bruce 1,045,494 sh (unchged)
» More
Q2 2016

EDAP Guru Trades in Q2 2016

Robert Bruce 1,045,494 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with EDAP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NAS:VIVE, OTCPK:ELEAF, OTCPK:ARTH, NAS:RWLK, NAS:NVTR, NAS:DRAD, OTCPK:ELXMF, OTCPK:AVMXF, NAS:AVGR, OTCPK:QTVLF, NAS:SPNE, NAS:SPAN, NAS:CGNT, OTCPK:DIZTF, NAS:MSON, OTCPK:TITXF, NAS:KOOL, NAS:FONR, AMEX:ELMD, OTCPK:BTCY » details
Traded in other countries:EDA.Germany,
Edap TMS SA is a holding company. The Company through its divisions HIFU and UDS,develops, produces and markets minimally invasive medical devices for urological diseases. Its divisions operate in Europe, the Americas, Asia and the rest of the world.

Edap TMS SA was incorporated on December 3, 1979 as a Societe Anonyme organized under the laws of the Republic of France for 60 years from the date of incorporation. It is a holding Company and is responsible for providing common services to its subsidiaries, including preparation and consolidation of the financial statements for the group, complying with the requirements of various regulatory agencies and maintaining the listing of its publicly held securities. Its activity is organized in two divisions: HIFU and UDS. Through these two divisions, the Company develops, produces and markets minimally invasive medical devices, mainly for urological diseases. It's HIFU and UDS divisions operate in Europe, the Americas, Asia and the rest of the world. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. Its HIFU business is quite seasonal and generally linked to lengthy hospital decision and investment processes. In addition to developing, manufacturing and marketing HIFU devices, the HIFU division also generates revenues from leasing equipment, as well as from the sale of disposables, spare parts and maintenance services. Currently, the only commercial product of the Company utilizing HIFU technology is the Ablatherm, an ultrasound guided HIFU device for the treatment of organ-confined prostate cancer. As of December 31, 2013, the HIFU division's patent portfolio contained 36 patents consisting of 16 in the United States, 18 in the European Union and Japan and 2 in Israel and the rest of the world. The Company belongs to 18 groups of patents covering key technologies related to therapeutic ultrasound principles, systems and associated software. The UDS division's main business is producing and marketing devices, known as lithotripters, for the treatment of urinary tract stones by means of ESWL technology. In addition to its manufacturing and selling of lithotripters, the UDS division also generates revenues from the leasing of lithotripters, as well as from the sale of disposables, spare parts and maintenance services. The UDS division offers the Sonolith i-move to small and mid-size hospitals, while the Sonolith i-sys is offered to large hospitals that can afford a fully dedicated and integrated lithotripter. Ablatherm-HIFU device competes with all current treatments for localized tumors, which include surgery, brachytherapy, radiotherapy, cryotherapy and hormonotherapy. The Company and its products are regulated in the United States by the FDA under a number of statutes including the Federal Food, Drug and Cosmetic Act.

Ratios

vs
industry
vs
history
P/E(ttm) 19.33
EDAP's P/E(ttm) is ranked higher than
68% of the 167 Companies
in the Global Medical Devices industry.

( Industry Median: 27.08 vs. EDAP: 19.33 )
Ranked among companies with meaningful P/E(ttm) only.
EDAP' s P/E(ttm) Range Over the Past 10 Years
Min: 5.1  Med: 27.85 Max: 52.09
Current: 19.33
5.1
52.09
Forward P/E 64.52
EDAP's Forward P/E is ranked lower than
91% of the 56 Companies
in the Global Medical Devices industry.

( Industry Median: 23.87 vs. EDAP: 64.52 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 19.33
EDAP's PE(NRI) is ranked higher than
68% of the 167 Companies
in the Global Medical Devices industry.

( Industry Median: 27.22 vs. EDAP: 19.33 )
Ranked among companies with meaningful PE(NRI) only.
EDAP' s PE(NRI) Range Over the Past 10 Years
Min: 5.03  Med: 27.85 Max: 52.09
Current: 19.33
5.03
52.09
Price/Owner Earnings (ttm) 20.00
EDAP's Price/Owner Earnings (ttm) is ranked lower than
99.99% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 31.34 vs. EDAP: 20.00 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
EDAP' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 1.11  Med: 10.08 Max: 239.44
Current: 20
1.11
239.44
P/B 3.04
EDAP's P/B is ranked lower than
52% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. EDAP: 3.04 )
Ranked among companies with meaningful P/B only.
EDAP' s P/B Range Over the Past 10 Years
Min: 0.49  Med: 2.71 Max: 18.27
Current: 3.04
0.49
18.27
P/S 1.98
EDAP's P/S is ranked higher than
62% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 3.23 vs. EDAP: 1.98 )
Ranked among companies with meaningful P/S only.
EDAP' s P/S Range Over the Past 10 Years
Min: 0.3  Med: 1.49 Max: 5.97
Current: 1.98
0.3
5.97
EV-to-EBIT 13.56
EDAP's EV-to-EBIT is ranked lower than
95% of the 164 Companies
in the Global Medical Devices industry.

( Industry Median: 22.51 vs. EDAP: 13.56 )
Ranked among companies with meaningful EV-to-EBIT only.
EDAP' s EV-to-EBIT Range Over the Past 10 Years
Min: -5776  Med: -6.85 Max: 207.8
Current: 13.56
-5776
207.8
EV-to-EBITDA 13.56
EDAP's EV-to-EBITDA is ranked lower than
96% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 16.88 vs. EDAP: 13.56 )
Ranked among companies with meaningful EV-to-EBITDA only.
EDAP' s EV-to-EBITDA Range Over the Past 10 Years
Min: -5776  Med: -6.85 Max: 207.8
Current: 13.56
-5776
207.8
Current Ratio 2.76
EDAP's Current Ratio is ranked higher than
53% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.56 vs. EDAP: 2.76 )
Ranked among companies with meaningful Current Ratio only.
EDAP' s Current Ratio Range Over the Past 10 Years
Min: 1.27  Med: 2.33 Max: 3.92
Current: 2.76
1.27
3.92
Quick Ratio 2.23
EDAP's Quick Ratio is ranked higher than
66% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 1.94 vs. EDAP: 2.23 )
Ranked among companies with meaningful Quick Ratio only.
EDAP' s Quick Ratio Range Over the Past 10 Years
Min: 1.07  Med: 2.07 Max: 3.51
Current: 2.23
1.07
3.51
Days Inventory 75.49
EDAP's Days Inventory is ranked higher than
86% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 132.35 vs. EDAP: 75.49 )
Ranked among companies with meaningful Days Inventory only.
EDAP' s Days Inventory Range Over the Past 10 Years
Min: 95.66  Med: 107.86 Max: 130.38
Current: 75.49
95.66
130.38
Days Sales Outstanding 111.28
EDAP's Days Sales Outstanding is ranked lower than
99.99% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: 68.07 vs. EDAP: 111.28 )
Ranked among companies with meaningful Days Sales Outstanding only.
EDAP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 110.95  Med: 187.9 Max: 249.93
Current: 111.28
110.95
249.93

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -11.40
EDAP's 3-Year Average Share Buyback Ratio is ranked lower than
72% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: -3.40 vs. EDAP: -11.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
EDAP' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -23  Med: -6.45 Max: 2.9
Current: -11.4
-23
2.9

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 3.97
EDAP's Price/Net Current Asset Value is ranked lower than
99.99% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 7.11 vs. EDAP: 3.97 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
EDAP' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.29  Med: 3.54 Max: 19.45
Current: 3.97
0.29
19.45
Price/Tangible Book 3.39
EDAP's Price/Tangible Book is ranked higher than
62% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 4.42 vs. EDAP: 3.39 )
Ranked among companies with meaningful Price/Tangible Book only.
EDAP' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.22  Med: 2.53 Max: 16.75
Current: 3.39
0.22
16.75
Price/Projected FCF 4.40
EDAP's Price/Projected FCF is ranked lower than
75% of the 123 Companies
in the Global Medical Devices industry.

( Industry Median: 2.18 vs. EDAP: 4.40 )
Ranked among companies with meaningful Price/Projected FCF only.
EDAP' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.41  Med: 5.33 Max: 20.14
Current: 4.4
0.41
20.14
Price/Median PS Value 1.33
EDAP's Price/Median PS Value is ranked lower than
66% of the 253 Companies
in the Global Medical Devices industry.

( Industry Median: 1.06 vs. EDAP: 1.33 )
Ranked among companies with meaningful Price/Median PS Value only.
EDAP' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.19  Med: 0.66 Max: 4
Current: 1.33
0.19
4
Price/Graham Number 1.71
EDAP's Price/Graham Number is ranked higher than
60% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 2.33 vs. EDAP: 1.71 )
Ranked among companies with meaningful Price/Graham Number only.
EDAP' s Price/Graham Number Range Over the Past 10 Years
Min: 0.08  Med: 0.86 Max: 3.76
Current: 1.71
0.08
3.76
Earnings Yield (Greenblatt) (%) 7.40
EDAP's Earnings Yield (Greenblatt) (%) is ranked higher than
50% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. EDAP: 7.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
EDAP' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.5  Med: 5.65 Max: 189209.4
Current: 7.4
0.5
189209.4

More Statistics

Revenue (TTM) (Mil) $38.97
EPS (TTM) $ 0.15
Beta0.68
Short Percentage of Float1.50%
52-Week Range $2.43 - 6.57
Shares Outstanding (Mil)28.73

Analyst Estimate

Dec16 Dec17 Dec18 Dec19
Revenue (Mil $) 47 54 60 66
EPS ($) 0.18 0.05 0.14 0.19
EPS w/o NRI ($) 0.18 0.05 0.14 0.19
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for NAS:EDAP

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
EDAP Installs Ablatherm Robotic® HIFU at Leading Academic Medical Center Sep 12 2016
EDAP Installs Ablatherm Robotic® HIFU at Leading Academic Medical Center Sep 12 2016
EDAP TMS to Present at the 18th Annual Rodman and Renshaw Global Investment Conference Sep 06 2016
EDAP TMS SA :EDAP-US: Earnings Analysis: Q1, 2016 By the Numbers : August 30, 2016 Aug 30 2016
EDAP Reports 69% Growth in HIFU Revenues and Operating Profit for First Half 2016 Aug 25 2016
Q2 2016 Edap Tms SA Earnings Release - Before Market Open Aug 25 2016
EDAP Reports 69% Growth in HIFU Revenues and Operating Profit for First Half 2016 Aug 25 2016
EDAP's Ablatherm® Robotic HIFU Treats First Patient at Henry Ford Hospital in Detroit Aug 22 2016
EDAP's Ablatherm® Robotic HIFU Treats First Patient at Henry Ford Hospital in Detroit Aug 22 2016
EDAP to Report Second Quarter 2016 Financial Results on August 25, 2016 Aug 11 2016
EDAP to Report Second Quarter 2016 Financial Results on August 25, 2016 Aug 11 2016
EDAP Announces First HIFU Treatments Performed in New England Jun 16 2016
First HIFU patient treated at Allied Urological Services in New York City with the Ablatherm®... Jun 14 2016
EDAP TMS SA :EDAP-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 Jun 08 2016
EDAP First Quarter 2016 Revenue Increases 40% Year-over-Year to €8.7 Million May 18 2016
EDAP to Report First Quarter 2016 Results on May 18, 2016 May 10 2016
EDAP Announces Presentations and Live Demonstrations of Ablatherm® Robotic HIFU at 2016 American... May 04 2016
EDAP Receives Brazilian Regulatory Approval for Focal One® HIFU Device Apr 28 2016
Houston Methodist Hospital, Houston, TX Acquires and Installs EDAP's Ablatherm® Robotic HIFU Apr 25 2016
EDAP's Ablatherm® Robotic HIFU Deployed by HIFU Solution Apr 18 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)